Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Lavillette

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Science Translational Medicine|August 5, 2011
A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaquesPierre Garrone, Anne-Catherine Fluckiger, Philippe E Mangeot, et al.
Plos Pathogens|December 28, 2017
Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Plos Pathogens|February 22, 2021
Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Journal of Virology|September 25, 2015
Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host RestrictionCaroline Marnata, Aure Saulnier, Dimitri Mompelat, et al.
Plos Pathogens|May 1, 2018
Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzeeJin-Won Youn, Su-Hyung Park, Dimitri Lavillette, et al.
Plos Pathogens|March 6, 2018
A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanismFlorian Douam, Floriane Fusil, Margot Enguehard, et al.
Emerging Microbes & Infections|December 29, 2021
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike proteinShiqi Xu, Yifan Wang, Yanxing Wang, et al.
Protein & Cell|November 9, 2020
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Rui Xiong, Leike Zhang, Shiliang Li, et al.
Nature Communications|January 12, 2021
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infectionsChao Zhang, Yifan Wang, Yuanfei Zhu, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Science Translational Medicine|August 5, 2011
A prime-boost strategy using virus-like particles pseudotyped for HCV proteins triggers broadly neutralizing antibodies in macaquesPierre Garrone, Anne-Catherine Fluckiger, Philippe E Mangeot, et al.
Plos Pathogens|December 28, 2017
Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Plos Pathogens|February 22, 2021
Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Journal of Virology|September 25, 2015
Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host RestrictionCaroline Marnata, Aure Saulnier, Dimitri Mompelat, et al.
Plos Pathogens|May 1, 2018
Correction: Histone demethylase LSD1 restricts influenza A virus infection by erasing IFITM3-K88 monomethylationJiaoyu Shan, Binbin Zhao, Zhao Shan, et al.
Hepatology (Baltimore, Md.)|December 1, 2005
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzeeJin-Won Youn, Su-Hyung Park, Dimitri Lavillette, et al.
Plos Pathogens|March 6, 2018
A protein coevolution method uncovers critical features of the Hepatitis C Virus fusion mechanismFlorian Douam, Floriane Fusil, Margot Enguehard, et al.
Emerging Microbes & Infections|December 29, 2021
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike proteinShiqi Xu, Yifan Wang, Yanxing Wang, et al.
Protein & Cell|November 9, 2020
Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2Rui Xiong, Leike Zhang, Shiliang Li, et al.
Nature Communications|January 12, 2021
Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infectionsChao Zhang, Yifan Wang, Yuanfei Zhu, et al.
Pageof 8